AML - ACUTE MYELOID LEUKEMIA
Clinical trials for AML - ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new AML - ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for AML - ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to keep deadly leukemia at bay after risky transplant
Disease control Recruiting nowThis study is testing whether a pill called Chidamide can help prevent a dangerous blood cancer (AML) from coming back after a stem cell transplant. It will involve about 134 patients who are at high risk of the cancer returning. One group will take the pill for up to two years, …
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New shot in the arm for leukemia patients Who've run out of options
Disease control Recruiting nowThis is the first study in people testing a new drug called CBX-250 for several types of advanced blood cancers that have come back or stopped responding to standard treatments. The main goal is to find a safe dose and see how well the body handles the drug, which is given as an …
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Crossbow Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists create 'Avatar' mice to hunt for better leukemia drugs
Knowledge-focused Recruiting nowThis study aims to speed up the discovery of better treatments for acute myeloid leukemia (AML). Researchers will collect blood and bone marrow samples from 25 patients with AML who are receiving standard care. They will implant these human cancer cells into special mice to creat…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Knowledge-focused
Last updated Apr 04, 2026 06:37 UTC
-
Cancer Drug's hidden effects on common medications revealed in new study
Knowledge-focused Recruiting nowThis study aims to understand how the cancer drug olutasidenib affects how the body processes other medications. Researchers will measure blood levels of several test drugs in 16 adult patients with specific genetic mutations in their cancers. The goal is to learn about potential…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase: PHASE4 • Sponsor: Rigel Pharmaceuticals • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC